CN111093667A - 配合维生素b1类的固体制剂 - Google Patents
配合维生素b1类的固体制剂 Download PDFInfo
- Publication number
- CN111093667A CN111093667A CN201880058625.XA CN201880058625A CN111093667A CN 111093667 A CN111093667 A CN 111093667A CN 201880058625 A CN201880058625 A CN 201880058625A CN 111093667 A CN111093667 A CN 111093667A
- Authority
- CN
- China
- Prior art keywords
- powder
- starch
- vitamin
- solid preparation
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
Description
Claims (8)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-135645 | 2017-07-11 | ||
JP2017135645 | 2017-07-11 | ||
PCT/JP2018/026112 WO2019013234A1 (ja) | 2017-07-11 | 2018-07-11 | ビタミンb1類を配合する固形製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111093667A true CN111093667A (zh) | 2020-05-01 |
Family
ID=65002020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880058625.XA Pending CN111093667A (zh) | 2017-07-11 | 2018-07-11 | 配合维生素b1类的固体制剂 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPWO2019013234A1 (zh) |
KR (1) | KR102636176B1 (zh) |
CN (1) | CN111093667A (zh) |
TW (1) | TWI821193B (zh) |
WO (1) | WO2019013234A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113082188A (zh) * | 2021-04-28 | 2021-07-09 | 重庆市畜牧科学院 | 一种抗胃肠道炎症的兽药制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61257923A (ja) * | 1985-05-10 | 1986-11-15 | Takeda Chem Ind Ltd | 固型状医薬組成物 |
US5089276A (en) | 1989-04-19 | 1992-02-18 | Takeda Chemical Industries, Ltd. | Calcium pantothenate composite |
JPH05105636A (ja) * | 1991-10-14 | 1993-04-27 | Lion Corp | 制酸剤組成物 |
JP3157233B2 (ja) * | 1991-11-22 | 2001-04-16 | エーザイ株式会社 | 水溶性薬物を含有した軟カプセル剤 |
JPH0952832A (ja) * | 1995-08-10 | 1997-02-25 | Takeda Chem Ind Ltd | 医薬組成物 |
JP2000016940A (ja) * | 1998-04-28 | 2000-01-18 | Takeda Chem Ind Ltd | ビタミンb▲12▼類含有組成物 |
JP2001097849A (ja) * | 1999-09-29 | 2001-04-10 | Eisai Co Ltd | 安定なフィルム錠 |
JP2004357506A (ja) * | 2003-05-30 | 2004-12-24 | Fancl Corp | ペット用サプリメント |
JP4841130B2 (ja) | 2004-10-12 | 2011-12-21 | 武田薬品工業株式会社 | 安定化されたビタミン製剤 |
US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
JP4775879B2 (ja) | 2004-11-17 | 2011-09-21 | 塩野義製薬株式会社 | ビタミン組成物 |
KR101299885B1 (ko) | 2005-05-27 | 2013-08-23 | 코와 가부시키가이샤 | 피로 회복을 위한 의약 |
JP5023546B2 (ja) | 2006-04-28 | 2012-09-12 | ゼリア新薬工業株式会社 | 経口固形製剤 |
JP5524130B2 (ja) * | 2011-05-19 | 2014-06-18 | 武田薬品工業株式会社 | 安定化されたビタミン製剤 |
JP5897916B2 (ja) * | 2012-01-31 | 2016-04-06 | アサヒフードアンドヘルスケア株式会社 | ビタミン含有錠剤及びその製造方法 |
JP6196847B2 (ja) * | 2012-08-30 | 2017-09-13 | 興和株式会社 | 防已含有組成物 |
-
2018
- 2018-07-11 TW TW107123944A patent/TWI821193B/zh active
- 2018-07-11 CN CN201880058625.XA patent/CN111093667A/zh active Pending
- 2018-07-11 KR KR1020207003358A patent/KR102636176B1/ko active IP Right Grant
- 2018-07-11 WO PCT/JP2018/026112 patent/WO2019013234A1/ja active Application Filing
- 2018-07-11 JP JP2019529751A patent/JPWO2019013234A1/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113082188A (zh) * | 2021-04-28 | 2021-07-09 | 重庆市畜牧科学院 | 一种抗胃肠道炎症的兽药制备方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20200026950A (ko) | 2020-03-11 |
TWI821193B (zh) | 2023-11-11 |
TW201907910A (zh) | 2019-03-01 |
KR102636176B1 (ko) | 2024-02-13 |
WO2019013234A1 (ja) | 2019-01-17 |
JPWO2019013234A1 (ja) | 2020-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUE032012T2 (en) | Anti-Abuse Drug Products | |
WO2005117895A2 (en) | Compositions comprising meloxicam | |
JP5979931B2 (ja) | 医薬組成物 | |
KR100369874B1 (ko) | 제산제조성물및약제조성물 | |
WO2007148786A1 (ja) | 安定化された固形製剤 | |
WO2013115171A1 (ja) | 苦味マスク顆粒含有口腔内崩壊錠 | |
HUE034511T2 (en) | Solid dosage form with low viscosity hydroxyalkylcellulose content | |
EP2217218A1 (en) | Improved tablet coating | |
EP2213306A1 (en) | Method of producing granules containing material of natural origin such as chinese orthodox medicine extract, crude drug extract, natural material extract or mixture thereof and method of producing tablets from the granules | |
AU2009285467B2 (en) | Film preparation containing loperamide hydrochloride | |
CN111093667A (zh) | 配合维生素b1类的固体制剂 | |
CN102451162A (zh) | 经口腔粘膜吸收的奥氮平药物 | |
WO2017047586A1 (ja) | 錠剤 | |
JP4052603B2 (ja) | 経口投与用製剤 | |
JP2014221847A (ja) | 糖衣製剤およびその製造方法 | |
EP3960161A1 (en) | Polyvinyl alcohol-containing granulated product and solid preparation | |
JP5198001B2 (ja) | 安定化された固形製剤 | |
CN1859922A (zh) | 医药组合物 | |
CN112770779B (zh) | 纤维素组合物、片剂及口腔崩解片 | |
JP7425560B2 (ja) | 固形製剤の製造方法 | |
CA2378987C (en) | A binder for pharmaceutical compositions | |
JP2018145181A (ja) | ビタミンb1類配合錠剤 | |
CN116568312A (zh) | 稳定的半固体可咀嚼凝胶组合物及其制作和使用方法 | |
KR101625344B1 (ko) | 세레콕시브 및 둘록세틴을 함유하는 약제학적 조성물 | |
TW202412752A (zh) | 固體製劑及其製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40026506 Country of ref document: HK |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Tokyo, Japan Applicant after: Alinamin Pharmaceutical Co.,Ltd. Address before: Tokyo, Japan Applicant before: Takeda consumer health Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Tokyo, Japan Applicant after: Alinamin Pharmaceutical Co.,Ltd. Address before: Tokyo, Japan Applicant before: Oscar Aike Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230329 Address after: Tokyo, Japan Applicant after: Oscar Aike Co.,Ltd. Address before: Tokyo, Japan Applicant before: Alinamin Pharmaceutical Co.,Ltd. |